Table 2 Overall quality of life (QoL) of patients entering substance use disorder treatment in Norway, 2012–2015
Men’s overall QoL | Women’s overall QoL | |||||
|---|---|---|---|---|---|---|
very good/good/neutral n = 99 | poor n = 168 | very poor n = 124 | very good/good/neutral n = 33 | poor n = 54 | very poor n = 69 | |
n (%) | n (%) | n (%) | n (%) | n (%) | n (%) | |
Age (mean (SD)) | 34.3 (10.3) | 33.4 (9.1) | 32.3 (9.6) | 31.6 (10.9) | 35.4 (11.1) | 33.8 (10.5) |
Single | 90 (91.8) | 157 (95.2) | 117 (95.1) | 30 (93.8) | 48 (90.6) | 63 (92.6) |
Norwegian-born | 86 (87.8) | 149 (91.4) | 117 (95.1) | 30 (93.8) | 48 (90.6) | 58 (84.1) |
Primary education or less | 56 (57.7) | 94 (57.3) | 77 (62.6) | 19 (59.4) | 32 (61.5) | 41 (61.2) |
Unemployed | 85 (87.6) | 138 (85.7) | 113 (93.4) | 27 (84.4) | 48 (90.6) | 62 (91.2) |
Has children | 47 (50.5) | 70 (42.7) | 48 (40.0) | 18 (58.1) | 26 (50.0) | 30 (44.1) |
Clinical anxiety symptoms | 48 (49.0)* | 80 (49.7) | 84 (68.9) | 13 (41.9)* | 30 (56.6) | 47 (69.1) |
Clinical depression symptoms | 44 (44.9)* | 84 (52.2) | 79 (64.8) | 11 (35.5)* | 33 (62.3) | 48 (70.6) |
Chronic disease(s) | 71 (72.4) | 113 (68.5) | 91 (74.0) | 26 (81.3) | 42 (79.2) | 53 (76.8) |
Physically inactive | 44 (44.9)* | 99 (60.4) | 76 (61.8) | 20 (62.5) | 21 (39.6) | 25 (36.2) |
Physically active | 54 (55.1) | 65 (39.6) | 47 (38.2) | 12 (37.5) | 4 (8.2) | 9 (14.8) |
Weight evaluation | ||||||
Satisfied with weight | 57 (61.3) a | 67 (43.2) | 52 (44.4) | 17 (53.1) | 17 (34.7) | 22 (36.1) |
Considers self underweight | 21 (22.6) | 48 (31.0) | 38 (32.5) | 4 (12.5) | 4 (8.2) | 9 (14.8) |
Considers self overweight | 15 (16.1) | 40 (25.8) | 27 (23.1) | 11 (34.4) | 28 (57.1) | 30 (49.2) |
Medication-free treatment | 42 (42.9) | 80 (48.5) | 68 (55.3) | 12 (37.5) | 23 (43.4) | 39 (56.5) |
OMT | 56 (57.1) | 85 (51.5) | 55 (44.7) | 20 (62.5) | 30 (56.6) | 30 (43.5) |
Injected, past 4 weeks. | 37 (37.8) | 55 (33.5) | 44 (36.1) | 11 (34.4) | 16 (30.2) | 29 (42.0) |
Substance user category | ||||||
Prescribed OMT and/or medications only | 4 (4.1) | 1 (0.6) | 1 (0.8) | 2 (6.3) a | 0 (0.0) | 0 (0.0) |
Substance- and medication-free | 1 (1.0) | 3 (1.8) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) |
Single-substance user | 7 (7.2) | 12 (7.4) | 6 (5.0) | 3 (9.4) | 2 (3.8) | 4 (5.8) |
Polysubstance user | 85 (87.6) | 147 (90.2) | 113 (94.2) | 27 (84.4) | 51 (96.2) | 65 (94.2) |
Previous SUD treatment in months, median | ||||||
Inpatient | 6.0 | 4.0 | 5.0 | 10.5 | 4.0 | 5.5 |
Outpatient | 4.0 | 6.0 | 9.0 | 13.0 | 12.5 | 12.0 |
Most used substance, past 6 months | ||||||
Alcohol | 7 (7.1) | 9 (5.5) | 7 (5.7) | 2 (6.3) | 6 (11.3) | 12 (17.4) |
Cannabis | 14 (14.3) | 37 (22.4) | 27 (22.0) | 2 (6.3) | 6 (11.3) | 5 (7.2) |
Heroin | 21 (21.6) | 34 (20.9) | 30 (24.6) | 10 (31.3) | 15 (28.3) | 19 (27.5) |
Methadone/buprenorphine | 32 (33.0)* | 37 (22.7) | 22 (18.0) | 10 (31.3)** | 12 (22.6) | 5 (7.2) |
Benzodiazepine | 6 (6.1) | 10 (6.1) | 7 (5.7) | 1 (3.1) | 6 (11.3) | 7 (10.1) |
Stimulant | 16 (16.3) | 33 (20.0) | 28 (22.8) | 7 (21.9) | 7 (13.2) | 21 (30.4) |
Social network | ||||||
Substance-free | 38 (38.8) a | 64 (38.8) | 31 (25.2) | 14 (45.2) | 12 (22.6) | 14 (20.6) |
Substance-using | 45 (45.9) | 76 (46.1) | 61 (49.6) | 14 (45.2) | 32 (60.4) | 45 (66.2) |
Socially isolated | 15 (15.3) | 25 (15.2) | 31 (25.2) | 3 (9.7) | 9 (17.0) | 9 (13.2) |
Stable recent living situation | 76 (77.6) | 132 (81.0) | 91 (75.2) | 28 (87.5) | 43 (81.1) | 49 (71.0) |
Eats most meals alone | 36 (38.7)** | 76 (47.2) | 76 (63.3) | 6 (19.4) | 18 (34.0) | 30 (44.1) |
East with someone else | 57 (61.3) | 85 (52.8) | 44 (36.7) | 25 (80.6) | 35 (66.0) | 38 (55.9) |
Recent living situation, past 4 weeks | ||||||
Homeless | 12 (12.2) | 16 (9.7) | 15 (12.3) | 1 (3.1) | 1 (1.9) | 11 (15.9) |
Temporary housing | 5 (5.1) | 2 (1.2) | 8 (6.6) | 4 (12.5) | 2 (3.8) | 5 (7.2) |
Institution | 25 (25.5) | 44 (26.7) | 26 (21.3) | 7 (21.9) | 10 (18.9) | 14 (20.3) |
Owned or rented | 47 (48.0) | 80 (48.5) | 60 (49.2) | 15 (46.9) | 30 (56.6) | 29 (42.0) |
Other | 9 (9.2) | 23 (13.9) | 13 (10.7) | 5 (15.6) | 10 (18.9) | 10 (14.5) |